Long-Term Follow-up Study of the Phase I/II Safety and Preliminary Efficacy of Human Central Nervous System Stem Cells (HuCNS-SC) Subretinal Transplantation in Subjects With Geographic Atrophy of Age-Related Macular Degeneration

Trial Profile

Long-Term Follow-up Study of the Phase I/II Safety and Preliminary Efficacy of Human Central Nervous System Stem Cells (HuCNS-SC) Subretinal Transplantation in Subjects With Geographic Atrophy of Age-Related Macular Degeneration

Discontinued
Phase of Trial: Phase I/II

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs Adult neural stem cells (Primary)
  • Indications Age-related macular degeneration
  • Focus Adverse reactions
  • Sponsors StemCells
  • Most Recent Events

    • 31 May 2016 Status changed from active, no longer recruiting to discontinued based on a business decision unrelated to any safety concerns.
    • 05 Feb 2015 Interim results published in a StemCells media release.
    • 05 Feb 2015 Status changed from recruiting to active, no longer recruiting, according to StemCells media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top